Authors

• Ryo Nishikawa (ORCID: https://orcid.org/0000-0001-5617-8068)
• Naoki Shinojima (ORCID: https://orcid.org/0000-0003-3352-7936)
• Noriko Fukuhara (ORCID: https://orcid.org/0000-0003-2682-2179)
• Arata Aoi
• Yoshiki Arakawa (ORCID: https://orcid.org/0000-0003-4626-4645)
• Kazuhiko Mishima
• Kazuhiko Sugiyama
• Motoo Nagane (ORCID: https://orcid.org/0000-0002-0018-1652)
• Hajime Yonezawa (ORCID: https://orcid.org/0000-0003-3144-992X)
• Yoshitaka Narita (ORCID: https://orcid.org/0000-0003-4303-6006)
• Katsunori Asai (ORCID: https://orcid.org/0000-0002-2616-1211)
• Yasuhito Terui

Institutions

• Kyorin University (JP)
• Kyoto University (JP)
• National Cancer Center (US)
• Tohoku University Hospital (JP)
• Osaka International Cancer Institute (JP)
• Ono Pharmaceutical (Japan) (JP)
• Kagoshima University Hospital (JP)
• Kumamoto University Hospital (JP)
• Hiroshima University Hospital (JP)
• Saitama International Medical Center (JP)
• Japanese Foundation For Cancer Research (JP)
• Saitama Medical University (JP)

Publication Details

Journal

Future Oncology

Published

2025-10-31

DOI

https://doi.org/10.1080/14796694.2025.2574838

Primary Topic

CNS Lymphoma Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

0.00